801 On Other Exchanges
801 is not on other exchanges.

golden meditech holdings ltd (801) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for GOLDEN MEDITECH HOLDINGS LTD (801)

Related News

No related news articles were found.

golden meditech holdings ltd (801) Related Businessweek News

No Related Businessweek News Found

golden meditech holdings ltd (801) Details

Golden Meditech Holdings Limited, an investment holding company, operates as an integrated healthcare enterprise in the People’s Republic of China. It operates through five segments: Medical Devices, Hospital Management, Medical Insurance Administration, Chinese Herbal Medicines, and Cord Blood Storage. The Medical Devices segment develops, manufactures, and sells medical devices and medical accessories. This segment also offers blood related medical devices, such as Autologous Blood Recovery System and its consumables. The Hospital Management segment offers hospital management services; and operates two hospitals in Beijing and Shanghai that specializes in haematology and a range of medical disciplines. The Medical Insurance Administration segment provides medical insurance administration services. This segment also provides claim processing and bill settlement services to medical insurance companies, hospitals, and policy holders. The Chinese Herbal Medicine segment is involved in the research, development, manufacture, and sale of Chinese herbal medicines. The Cord Blood Bank segment provides cord blood stem cell examination, processing, separation, storage, and other related services. The company was formerly known as Golden Meditech Company Limited and changed its name to Golden Meditech Holdings Limited in March 2010. Golden Meditech Holdings Limited was incorporated in 2001 and is headquartered in Beijing, the People’s Republic of China.

736 Employees
Last Reported Date: 06/28/16
Founded in 2001

golden meditech holdings ltd (801) Top Compensated Officers

Founder, Chairman, Chief Executive Officer an...
Total Annual Compensation: $13.5M
Company Secretary and Executive Director
Total Annual Compensation: $12.0M
Total Annual Compensation: $555.0K
Compensation as of Fiscal Year 2016.

golden meditech holdings ltd (801) Key Developments

Golden Meditech Holdings Limited Announces Resignation of Yu Kwok Kuen, Harry as Director and Chief Operating Officer

The board of directors of Golden Meditech Holdings Limited announced that Mr. Yu Kwok Kuen, Harry resigned as an executive Director and Chief Operating Officer of the Company with effect from 30 June 2016 due to his decision to devote more time to his personal endeavours. The Board and Mr. Yu confirmed that there is no disagreement with each other and that there are no matters relating to Mr. Yu's resignation that need to be brought to the attention of the shareholders of the Company.

Golden Meditech Holdings Limited Reports Audited Consolidated Earnings Results for the Year Ended March 31, 2016

Golden Meditech Holdings Limited reported audited consolidated earnings results for the year ended March 31, 2016. For the year, the company reported revenue of HKD 281,558,000 against HKD 269,582,000 a year ago. Loss from operations was HKD 265,240,000 against HKD 34,862,000 a year ago. Loss before taxation was HKD 426,957,000 against HKD 852,529,000 a year ago. Loss for the year from continuing operations was HKD 431,284,000 against HKD 870,971,000 a year ago. Loss attributable to the company's equity shareholders was HKD 405,561,000 or 29.1 cents against HKD 863,747,000 or 46.3 cents a year ago. Loss before interest, taxes, depreciation and amortization was HKD 181,401,000 against HKD 694,798,000 a year ago. Basic loss per share from continuing operations was 17.2 cents against 49.6 cents a year ago. Total revenue from continuing operations was increased by 4.4% year-on-year, which was mainly driven by the medical devices segment. Loss attributable to the company's equity shareholders from continuing operations was down 53.0% year-on-year. The decrease was mainly attributable to the absence of a one-off impairment provision. Net cash generated from operating activities was HKD 543,647,000 against HKD 949,390,000 a year ago. Payments for purchase of property, plant and equipment was HKD 158,671,000 against HKD 273,994,000 a year ago.

Golden Meditech Holdings Limited Not to Recommend Payment of Final Dividend in Respect of the Year Ended 31 March 2016

Golden Meditech Holdings Limited announced that the board of directors did not recommend the payment of a final dividend in respect of the year ended 31 March 2016 in light of the ongoing transaction with respect to the disposal of 65.4% interest in China Cord Blood Corporation (CCBC) against a final dividend of 1.3 cents per ordinary share of HKD 0.20 each in the share capital of the company.


The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

801 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 801.
View Industry Companies

Industry Analysis


Industry Average

Valuation 801 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 0.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact GOLDEN MEDITECH HOLDINGS LTD, please visit www.goldenmeditech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.